Geburtsdatum
Alter
25.12.1988 (Alter: 35)
35
(25.12.1988)
Draft
Saison 9 / #5 (LAC)
Saison 9 / #5
(LAC)
Career Earnings
115.20 Mio
Gesamt
TOT
22
10658
4201
735
1223
368
63
435
1008
1008
591
1661
371
426
137
489
61
506
208
4
3
0
4201
Schnitt
AVG
21.1
8.3
1.5
2.4
0.7
0.1
0.9
2.0
3.8
1.2
3.3
0.7
0.8
0.3
1.0
0.1
52.6%
35.6%
87.1%
23.0
9.5
0.2
0.1
0.0
8.3
17.5%
12.0
2.8
0.75
0.13
Career High
High
37
26
9
11
4
4
5
8
16
6
14
11
11
3
5
47
Gesamt
TOT
8
604
190
57
68
15
4
30
0
25
25
82
11
13
8
32
-60
27
17
0
0
0
218
Schnitt
AVG
22.4
7.0
2.1
2.5
0.6
0.1
1.1
1.9
3.7
0.9
3.0
0.4
0.5
0.3
1.2
-2.2
52.0%
30.5%
84.6%
3.4
2.1
0.0
0.0
0.0
8.1
0.0%
8.9
0.0
0.00
0.00
Career High
High
20
5
2
3
1
0
1
1
2
1
2
0
0
1
3
12
Gesamt
TOT
438
149
30
40
22
2
19
40
69
20
51
9
11
6
28
-10
29
0
0
0
0
144
Schnitt
AVG
15.1
5.1
1.0
1.4
0.8
0.1
0.7
1.4
2.4
0.7
1.8
0.3
0.4
0.2
1.0
-0.3
58.0%
39.2%
81.8%
5.0
14.5%
11.3
2.11
0.79
0.07
Season High
High
21
14
3
4
3
2
2
5
7
3
5
3
3
1
3
11
75.0%
75.0%
50.0%
9
28.2%
43.0
4.00
3.00
2.00
38
76
ORL
3.6
15.1
5.1
1.0
1.4
0.8
0.1
0.7
1.4
2.4
0.7
1.8
0.3
0.4
0.2
1.0
-0.3
58.0%
39.2%
81.8%
29
0
0
0
0
5.0
14.5%
11.3
2.11
0.79
0.07
37
76
PHX
3.0
9.5
4.5
0.5
1.5
0.0
0.0
0.3
0.8
0.8
1.0
2.5
0.0
0.0
0.0
0.0
2.0
100.0%
40.0%
4
0
0
0
0
3.5
17.1%
16.6
6.00
36
75
UTA
2.0
14.6
3.0
1.3
1.7
0.2
0.0
0.4
0.7
1.2
0.4
1.0
0.6
0.6
0.1
0.6
1.5
56.3%
38.5%
94.1%
27
0
0
0
0
2.8
9.2%
8.8
4.50
0.35
0.00
35
75
PHX
4.9
19.3
7.7
1.2
2.5
0.4
0.1
1.0
1.3
2.4
1.5
4.1
0.6
0.8
0.1
1.3
-3.2
51.5%
37.4%
81.0%
28
1
0
0
0
7.9
17.0%
10.8
2.45
0.30
0.05
34
77
NYK
4.1
14.7
8.6
1.1
2.0
0.2
0.1
0.7
1.7
2.8
1.6
3.6
0.5
0.5
0.1
0.5
-2.5
59.5%
44.4%
87.5%
15
0
0
0
0
7.3
23.5%
18.0
3.00
0.43
0.14
33
78
NYK
4.1
16.1
11.0
1.5
1.4
0.3
0.1
0.5
2.6
4.9
1.8
4.0
0.2
0.3
0.3
0.3
-0.6
53.7%
46.5%
85.7%
25
0
1
0
0
9.5
26.9%
20.0
3.00
1.00
0.43
32
82
BOS
4.4
26.1
7.1
2.2
5.3
0.9
0.3
1.2
1.8
3.0
1.0
2.7
0.5
0.5
0.5
2.0
-0.1
58.3%
38.2%
93.3%
28
28
0
3
0
7.2
12.0%
12.4
4.38
0.44
0.12
31
78
CLE
4.4
19.6
3.6
1.5
2.4
0.7
0.0
0.6
1.2
2.2
0.3
1.7
0.2
0.2
0.2
1.1
-1.5
55.9%
15.2%
83.3%
27
0
0
0
0
4.6
11.0%
6.5
4.13
0.62
0.03
30
79
HOU
4.9
23.1
9.4
1.7
2.7
0.9
0.3
1.3
2.5
4.4
1.3
4.3
0.5
0.7
0.2
1.3
-3.9
57.6%
29.7%
71.4%
21
9
0
0
0
10.3
20.0%
11.1
2.07
0.64
0.21
28
77
MEM
4.9
27.1
5.8
1.3
2.4
0.6
0.1
1.2
1.2
2.4
1.1
4.1
0.1
0.2
0.1
1.1
-13.8
49.2%
27.0%
60.0%
27
27
0
0
0
7.8
13.0%
4.7
2.03
0.53
0.10
27
81
MIA
11.1
23.5
6.6
0.9
1.9
0.5
0.1
0.6
1.3
2.3
1.3
3.8
0.3
0.4
0.3
0.9
-0.4
56.5%
34.2%
75.0%
40
43
1
0
0
6.9
14.0%
8.3
3.17
0.56
0.11
26
81
CHI
11.1
19.2
9.5
1.8
3.3
0.7
0.2
1.0
2.6
5.3
1.0
3.1
1.4
1.6
0.7
0.9
6.0
49.3%
32.3%
86.4%
41
0
1
0
0
10.1
22.0%
16.0
3.29
0.78
0.22
25
80
IND
11.1
25.7
10.6
1.5
2.9
1.1
0.1
1.3
2.2
4.5
1.6
4.4
1.4
1.6
0.4
1.0
-1.8
48.6%
36.7%
86.4%
41
41
0
0
0
10.9
12.0%
12.3
2.25
1.10
0.10
24
81
DEN
7.5
19.9
11.9
1.6
2.8
0.8
0.1
1.4
3.5
6.5
0.7
2.6
2.8
3.0
0.3
1.3
0.8
53.8%
27.1%
93.5%
41
0
1
0
0
11.8
13.0%
17.2
2.02
0.62
0.08
23
77
DET
7.5
26.6
8.5
1.0
1.7
0.8
0.1
0.9
2.2
4.4
1.2
2.8
0.6
0.6
0.3
1.2
-0.1
50.0%
42.9%
100.0%
25
23
0
0
0
8.4
8.0%
9.2
1.87
0.67
0.10
22
77
MIN
7.5
26.1
12.0
1.4
2.2
1.4
0.3
0.6
2.6
4.9
2.2
5.1
0.3
0.3
0.1
0.9
14.4
52.3%
43.1%
100.0%
27
27
0
0
0
10.7
0.0%
15.0
3.75
1.61
0.35
21
78
MIL
5.3
19.8
9.6
1.3
1.6
0.8
0.1
0.9
3.2
6.2
0.9
3.0
0.4
0.6
0.1
0.8
-5.0
51.8%
29.6%
80.0%
9
9
0
0
0
10.4
0.0%
11.7
1.75
1.00
0.14
20
80
CHI
5.3
16.9
7.1
1.4
1.4
1.0
0.1
0.5
1.8
3.9
1.0
2.5
0.5
0.8
0.1
0.6
4.8
47.2%
39.4%
66.7%
28
0
0
0
0
7.3
0.0%
13.0
2.67
1.69
0.19
14
74
CLE
0.0
26.8
15.2
3.2
2.9
1.3
0.2
0.4
2.8
5.2
2.1
5.6
0.0
0.0
0.0
0.0
53.0%
37.8%
16
11.2
0.0%
15.6
7.67
9
0
LAC
0.0
14.7
6.0
1.0
1.6
0.4
0.0
0.3
2.0
4.6
0.6
3.0
0.3
0.3
0.0
0.9
0.0
43.8%
19.0%
100.0%
7
0
0
0
0
8.0
0.0%
7.4
5.50
0.50
0.00
2024-06-04
06-04
ORL
HOU
12
0
0
3
1
0
0
0
1
0
0
0
0
0
0
4
0.0%
--
--
1
3.5%
8.2
--
--
--
2024-06-02
06-02
ORL
SAS
12
0
1
1
0
0
0
0
0
0
3
0
0
0
0
3
--
0.0%
--
3
10.7%
-4.7
--
--
--
2024-06-02
06-02
ORL
NOP
20
14
3
1
2
0
0
1
2
3
5
3
3
0
3
7
57.1%
60.0%
100.0%
8
17.3%
27.4
--
0.67
0.00
2024-06-01
06-01
ORL
UTA
8
7
1
1
1
0
0
2
2
1
1
0
0
0
0
-2
100.0%
100.0%
--
3
17.2%
43.0
--
--
--
2024-05-30
05-30
ORL
PHI
13
2
0
4
0
0
1
1
2
0
0
0
0
0
1
-6
50.0%
--
--
3
9.6%
7.3
4.00
0.00
0.00
2024-05-25
05-25
ORL
DEN
12
2
0
2
1
0
1
1
2
0
1
0
0
0
2
11
33.3%
0.0%
--
4
13.6%
3.0
2.00
0.50
0.00
2024-05-24
05-24
ORL
DET
12
2
0
0
0
0
0
1
1
0
1
0
0
0
1
-10
50.0%
0.0%
--
2
7.1%
2.1
--
0.00
0.00
2024-05-23
05-23
ORL
MIL
10
5
1
0
0
0
1
1
3
1
2
0
0
1
2
-11
40.0%
50.0%
--
6
28.2%
4.7
0.00
0.00
0.00
2024-05-20
05-20
ORL
CHA
13
2
2
1
0
0
0
1
1
0
2
0
0
0
0
-12
33.3%
0.0%
--
3
11.2%
4.6
--
--
--
2024-05-20
05-20
ORL
MIA
12
4
0
0
3
0
0
2
2
0
1
0
0
0
0
-9
66.7%
0.0%
--
3
11.6%
20.4
--
--
--
2024-05-10
05-10
ORL
DAL
16
0
1
2
0
0
0
0
1
0
1
0
0
1
3
-6
0.0%
0.0%
--
2
5.7%
-1.1
--
0.00
0.00
2024-04-27
04-27
ORL
LAC
19
4
1
0
2
0
1
2
2
0
2
0
0
0
0
9
50.0%
0.0%
--
5
11.9%
7.1
0.00
--
--
2024-04-27
04-27
ORL
MIN
16
2
2
4
3
0
2
1
1
0
1
0
0
0
1
8
50.0%
0.0%
--
4
10.2%
13.1
2.00
3.00
0.00
2024-04-22
04-22
ORL
TOR
11
2
0
4
0
0
1
1
1
0
3
0
0
0
1
-7
25.0%
0.0%
--
5
19.4%
2.7
4.00
0.00
0.00
2024-04-16
04-16
ORL
PHX
16
7
1
1
0
0
2
2
3
1
1
0
0
0
2
8
75.0%
100.0%
--
6
16.9%
9.2
0.50
0.00
0.00
2024-04-16
04-16
ORL
BKN
17
7
2
2
1
0
0
3
3
0
3
1
2
0
0
-7
50.0%
0.0%
50.0%
7
17.5%
15.7
--
--
--
2024-04-06
04-06
ORL
NYK
15
3
1
1
1
0
0
0
1
1
3
0
0
1
0
-6
25.0%
33.3%
--
4
10.8%
8.2
--
--
--
2024-03-23
03-23
ORL
IND
14
6
1
2
0
0
0
3
4
0
2
0
0
0
1
-5
50.0%
0.0%
--
6
16.8%
12.3
--
0.00
0.00
2024-03-21
03-21
ORL
OKC
20
13
1
1
0
0
0
5
7
1
2
0
0
0
1
7
66.7%
50.0%
--
9
19.9%
20.1
--
0.00
0.00
2024-03-20
03-20
ORL
CHI
16
3
2
1
0
0
1
0
3
1
1
0
0
1
1
3
25.0%
100.0%
--
5
13.4%
2.0
1.00
0.00
0.00
2024-03-19
03-19
ORL
WAS
16
9
0
0
0
0
0
0
3
3
4
0
0
0
0
2
42.9%
75.0%
--
7
20.1%
13.3
--
--
--
2024-03-18
03-18
ORL
SAC
20
9
0
1
0
2
2
3
4
1
2
0
0
0
1
-2
66.7%
50.0%
--
8
15.5%
12.7
0.50
0.00
2.00
2024-03-18
03-18
ORL
ATL
21
13
1
1
2
0
1
2
5
3
3
0
0
0
2
3
62.5%
100.0%
--
9
21.7%
21.3
1.00
1.00
0.00
2024-03-16
03-16
ORL
POR
19
8
2
4
2
0
1
3
4
0
0
2
2
1
1
9
75.0%
--
100.0%
6
15.3%
23.8
4.00
2.00
0.00
2024-03-13
03-13
ORL
GSW
17
7
1
1
1
0
1
1
3
1
2
2
2
0
1
-9
40.0%
50.0%
100.0%
7
18.0%
11.4
1.00
1.00
0.00
2024-03-10
03-10
ORL
BOS
16
8
1
1
0
0
0
2
3
1
1
1
2
1
0
-5
75.0%
100.0%
50.0%
5
14.7%
19.3
--
--
--
2024-03-10
03-10
ORL
LAL
14
0
2
0
0
0
2
0
2
0
1
0
0
0
2
7
0.0%
0.0%
--
5
14.5%
-13.7
0.00
0.00
0.00
2024-03-09
03-09
ORL
CLE
14
6
3
0
2
0
2
0
1
2
2
0
0
0
2
6
66.7%
100.0%
--
5
16.2%
14.6
0.00
1.00
0.00
2024-03-09
03-09
ORL
MEM
17
4
0
1
0
0
0
2
2
0
1
0
0
0
0
0
66.7%
0.0%
--
3
8.7%
8.2
--
--
--